載入...
72 Use of Palivizumab in Canada; Data from the CARESS registry 2005–2017
BACKGROUND: The Canadian Registry of Palivizumab (CARESS) tracks palivizumab utilization and hospitalizations for respiratory illness (RI) and respiratory syncytial virus (RSVH) in high-risk infants, whatever the indication. The decision to administer palivizumab is taken by individual clinicians at...
Na minha lista:
| 發表在: | Paediatr Child Health |
|---|---|
| Main Authors: | , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Oxford University Press
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6543371/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/pch/pxz066.071 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|